A Comparison between Perceptions of Psychiatric Outpatients and Psychiatrists Regarding Benzodiazepine Use and Decision Making for Its Discontinuation: A Cross-Sectional Survey in Japan

Author:

Aoki Yumi12,Takeshima Masahiro3ORCID,Tsuboi Takashi2,Katsumoto Eiichi4ORCID,Udagawa Ken5,Inada Ken6,Watanabe Koichiro2,Mishima Kazuo3ORCID,Takaesu Yoshikazu27

Affiliation:

1. Psychiatric and Mental Health Nursing, St. Luke’s International University, Tokyo 104-0044, Japan

2. Department of Neuropsychiatry, Kyorin University School of Medicine, Tokyo 181-8611, Japan

3. Department of Neuropsychiatry, Akita University Graduate School of Medicine, Akita 010-8543, Japan

4. Katsumoto Mental Clinic, Osaka 543-0056, Japan

5. Community Mental Health & Welfare Bonding Organization, Chiba 272-003, Japan

6. Department of Psychiatry, Kitasato University School of Medicine, Kanagawa 252–0374, Japan

7. Department of Neuropsychiatry, Graduate School of Medicine, University of the Ryukyus, Okinawa 903-0215, Japan

Abstract

Background: Although long-term use of benzodiazepines and z-drugs (BZDs) is not recommended, little is known about the stakeholders’ perceptions. This study aimed to assess and compare the perceptions of BZD use and decision making regarding its discontinuation between psychiatric outpatients and psychiatrists. Methods: A cross-sectional survey was conducted. Results: Of 104 outpatients, 92% were taking hypnotics and 96% were taking anxiolytics for ≥a year, while 49% were willing to taper hypnotic/anxiolytics within a year of starting. Most psychiatrists felt that “patient and psychiatrist make the decision together on an equal basis” compared to patients (p < 0.001), while more patients felt that “the decision is (was) made considering the psychiatrists’ opinion” compared to psychiatrists (p < 0.001). Of 543 psychiatrists, 79% reported “patients were not willing to discontinue hypnotic/anxiolytic” whereas a certain number of patients conveyed “psychiatrists did not explain in enough detail about hypnotic/anxiolytic discontinuation such as procedure (18.3%), timing (19.2%), and appropriate condition (14.4%)”. Conclusion: The results suggest that the majority of psychiatric outpatients were taking hypnotic/anxiolytics for a long time against their will. There might be a difference in perceptions toward hypnotic/anxiolytic use and decision making for its discontinuation between psychiatric outpatients and psychiatrists. Further research is necessary to fill this gap.

Funder

The Ministry of Health, Labor and Welfare of Japan

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health

Reference42 articles.

1. The Benzodiazepine Binding Sites of GABAA Receptors;Sigel;Trends Pharmacol. Sci.,2018

2. Potentially inappropriate medications in nursing homes and the community older adults using the French health insurance database;Drusch;Pharmacoepidemiol. Drug Saf.,2023

3. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders;Brunette;Psychiatr. Serv.,2003

4. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the global burden of disease study 2017. Lancet, 392, 1789–1858.

5. Long-term diazepam therapy and clinical outcome;Rickels;JAMA,1983

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3